CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 87.41% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Scan to Download iOS&Android APP

Trade GoodRx Holdings, Inc. - GDRX CFD

5.28
6.45%
0.07
Low: 4.91
High: 5.36
Market Trading Hours* (UTC) Opens on Monday at 14:30

Mon - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.07
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.030779 %
Charges from borrowed part ($-1.23)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.030779%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.013666 %
Charges from borrowed part ($-0.55)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.013666%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 20%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 4.96
Open* 4.91
1-Year Change* -78.09%
Day's Range* 4.91 - 5.36
52 wk Range 3.82-30.89
Average Volume (10 days) 1.71M
Average Volume (3 months) 37.53M
Market Cap 2.11B
P/E Ratio -100.00K
Shares Outstanding 709.92M
Revenue 795.70M
EPS -0.17
Dividend (Yield %) N/A
Beta -100.00K
Next Earnings Date Feb 27, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jan 27, 2023 5.28 0.39 7.98% 4.89 5.36 4.85
Jan 26, 2023 4.96 0.09 1.85% 4.87 4.99 4.78
Jan 25, 2023 4.79 -0.19 -3.82% 4.98 5.04 4.65
Jan 24, 2023 5.16 -0.31 -5.67% 5.47 5.60 5.14
Jan 23, 2023 5.60 0.43 8.32% 5.17 5.68 5.17
Jan 20, 2023 5.27 0.06 1.15% 5.21 5.32 5.08
Jan 19, 2023 5.15 0.21 4.25% 4.94 5.19 4.91
Jan 18, 2023 5.18 -0.13 -2.45% 5.31 5.47 5.18
Jan 17, 2023 5.33 0.19 3.70% 5.14 5.45 5.03
Jan 13, 2023 5.25 0.18 3.55% 5.07 5.26 4.93
Jan 12, 2023 5.17 0.00 0.00% 5.17 5.21 5.02
Jan 11, 2023 5.16 0.06 1.18% 5.10 5.22 5.01
Jan 10, 2023 5.08 0.19 3.89% 4.89 5.10 4.87
Jan 9, 2023 4.94 0.10 2.07% 4.84 5.06 4.84
Jan 6, 2023 4.82 0.13 2.77% 4.69 4.90 4.50
Jan 5, 2023 4.73 0.11 2.38% 4.62 4.77 4.60
Jan 4, 2023 4.82 0.10 2.12% 4.72 4.92 4.59
Jan 3, 2023 4.69 0.04 0.86% 4.65 4.97 4.60
Dec 30, 2022 4.63 0.11 2.43% 4.52 4.63 4.46
Dec 29, 2022 4.70 0.44 10.33% 4.26 4.73 4.26

GoodRx Holdings, Inc. Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total revenue 99.377 157.24 249.522 388.224 550.7 745.424
Revenue 99.377 157.24 249.522 388.224 550.7 745.424
Cost of Revenue, Total 1.23 3.075 6.035 14.016 29.587 46.716
Gross Profit 98.147 154.165 243.487 374.208 521.113 698.708
Total Operating Expense 80.602 110.596 175.128 253.425 826.419 732.018
Selling/General/Admin. Expenses, Total 64.541 83.26 112.536 191.659 715.586 524.903
Research & Development 5.742 11.501 43.894 29.3 61.816 125.86
Depreciation / Amortization 9.089 9.099 9.806 13.573 18.43 34.539
Operating Income 18.775 46.644 74.394 134.799 -275.719 13.406
Interest Income (Expense), Net Non-Operating -3.52 -6.946 -22.039 -48.854 -27.753 -23.583
Other, Net -0.154 0.005 -0.007 -2.967 0.022 0
Net Income Before Taxes 15.101 39.703 52.348 82.978 -303.45 -10.177
Net Income After Taxes 8.913 28.772 43.793 66.048 -293.623 -25.254
Net Income Before Extra. Items 8.913 28.772 43.793 66.048 -293.623 -25.254
Net Income 8.913 28.772 43.793 66.048 -293.623 -25.254
Income Available to Common Excl. Extra. Items 8.913 28.772 43.793 66.048 -293.623 -25.254
Income Available to Common Incl. Extra. Items 8.913 28.772 43.793 66.048 -293.623 -25.254
Diluted Net Income 8.913 28.772 43.793 66.048 -293.623 -25.254
Diluted Weighted Average Shares 383.223 383.223 383.223 383.223 274.696 409.981
Diluted EPS Excluding Extraordinary Items 0.02326 0.07508 0.11428 0.17235 -1.0689 -0.0616
Dividends per Share - Common Stock Primary Issue 0 0 0 0 0
Diluted Normalized EPS 0.02326 0.082 0.12051 0.18248 -1.06654 -0.03893
Unusual Expense (Income) 3.661 2.857 4.877 1 0
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022
Total revenue 160.431 176.635 195.102 213.256 203.329
Revenue 160.431 176.635 195.102 213.256 203.329
Cost of Revenue, Total 10.428 11.09 11.271 13.927 12.28
Gross Profit 150.003 165.545 183.831 199.329 191.049
Total Operating Expense 165.429 176.986 188.103 201.5 183.568
Selling/General/Admin. Expenses, Total 123.48 127.96 131.598 141.865 124.873
Research & Development 26.16 29.567 35.073 35.06 35.042
Depreciation / Amortization 5.361 8.369 10.161 10.648 11.373
Operating Income -4.998 -0.351 6.999 11.756 19.761
Interest Income (Expense), Net Non-Operating -5.889 -5.893 -5.915 -5.886 -5.817
Net Income Before Taxes -10.887 -6.244 1.084 5.87 13.944
Net Income After Taxes 1.668 31.061 -18.069 -39.914 12.293
Net Income Before Extra. Items 1.668 31.061 -18.069 -39.914 12.293
Net Income 1.668 31.061 -18.069 -39.914 12.293
Income Available to Common Excl. Extra. Items 1.668 31.061 -18.069 -39.914 12.293
Income Available to Common Incl. Extra. Items 1.668 31.061 -18.069 -39.914 12.293
Diluted Net Income 1.668 31.061 -18.069 -39.914 12.8213
Diluted Weighted Average Shares 429.577 428.867 411.223 414.068 427.378
Diluted EPS Excluding Extraordinary Items 0.00388 0.07243 -0.04394 -0.09639 0.03
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS 0.00849 0.07819 -0.0402 -0.08841 0.03471
Other, Net 0 0 0
Unusual Expense (Income) 0
Dilution Adjustment 0.52834
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total Current Assets 73.071 86.582 1086.37 1088.83
Cash and Short Term Investments 34.6 26.05 968.691 941.109
Cash 34.6 26.05 968.691 941.109
Total Receivables, Net 35.023 48.129 97.293 126.411
Accounts Receivable - Trade, Net 33.359 48.129 68.729 118.08
Prepaid Expenses 3.448 12.403 17.484 21.307
Total Assets 314.791 386.796 1470.11 1607.62
Property/Plant/Equipment, Total - Net 0.988 34.175 50.769 49.317
Property/Plant/Equipment, Total - Gross 1.542 35.442 52.899 55.146
Accumulated Depreciation, Total -0.554 -1.267 -2.13 -5.829
Goodwill, Net 220.42 236.225 261.116 329.696
Intangibles, Net 18.27 26.445 56.719 133.778
Other Long Term Assets, Total 2.042 3.369 15.142 6.007
Total Current Liabilities 16.62 33.373 59.551 81.113
Accounts Payable 7.2 7.851 10.291 17.501
Accrued Expenses 3.732 13.691 35.379 49.714
Notes Payable/Short Term Debt 0 0 0 0
Current Port. of LT Debt/Capital Leases 5.43 7.029 7.029 7.029
Other Current Liabilities, Total 0.258 4.802 6.852 6.869
Total Liabilities 740.209 737.369 758.755 775.945
Total Long Term Debt 716.806 663.893 659.888 655.858
Long Term Debt 716.806 663.893 659.888 655.858
Deferred Income Tax 3.456 0.244
Other Liabilities, Total 3.327 40.103 39.316 38.73
Total Equity -425.418 -350.573 711.359 831.68
Redeemable Preferred Stock 737.009 737.009 0 0
Common Stock 0.451 0.46 0.039 0.04
Retained Earnings (Accumulated Deficit) -1162.88 -1096.83 -1390.45 -1415.71
Total Liabilities & Shareholders’ Equity 314.791 386.796 1470.11 1607.62
Total Common Shares Outstanding 383.223 383.223 391.66 398.681
Additional Paid-In Capital 8.788 2101.77 2247.35
Other Current Assets, Total 2.9 0
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Total Current Assets 1123.38 1075.75 1051.54 1088.83 994.723
Cash and Short Term Investments 990.463 894.703 912.023 941.109 845.427
Cash 990.463 894.703 912.023 941.109 845.427
Total Receivables, Net 115.791 166.801 126.38 126.411 129.107
Accounts Receivable - Trade, Net 74.399 87.004 98.511 118.08 123.281
Prepaid Expenses 14.226 14.246 13.137 21.307 20.189
Other Current Assets, Total 2.9 0 0 0
Total Assets 1510.97 1586.93 1614.36 1607.62 1538.33
Property/Plant/Equipment, Total - Net 50.576 49.007 47.806 49.317 49.542
Goodwill, Net 261.116 320.196 329.696 329.696 334.642
Intangibles, Net 60.387 126.776 133.331 133.778 138.495
Other Long Term Assets, Total 15.515 15.2 51.992 6.007 20.926
Total Current Liabilities 63.049 65.491 72.681 81.113 59.364
Accounts Payable 15.101 18.378 17.279 17.501 12.82
Accrued Expenses 32.115 31.185 40.163 49.714 29.196
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 7.029 7.029 7.029 7.029 7.029
Other Current Liabilities, Total 8.804 8.899 8.21 6.869 10.319
Total Liabilities 761.915 762.535 767.969 775.945 751.821
Total Long Term Debt 658.883 657.877 656.868 655.858 654.845
Long Term Debt 658.883 657.877 656.868 655.858 654.845
Other Liabilities, Total 39.983 39.167 38.42 38.73 37.215
Total Equity 749.059 824.394 846.396 831.68 786.507
Common Stock 0.039 0.039 0.039 0.04 0.04
Additional Paid-In Capital 2137.8 2182.08 2222.15 2247.35 2189.88
Retained Earnings (Accumulated Deficit) -1388.79 -1357.72 -1375.79 -1415.71 -1403.41
Total Liabilities & Shareholders’ Equity 1510.97 1586.93 1614.36 1607.62 1538.33
Total Common Shares Outstanding 392.457 395.393 398.681 398.681 396.132
Redeemable Preferred Stock 0 0 0
Deferred Income Tax 0.244 0.397
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Net income/Starting Line 43.793 66.048 -293.623 -25.254
Cash From Operating Activities 45.253 83.286 131.341 178.779
Cash From Operating Activities 9.806 13.573 18.43 34.539
Deferred Taxes -2.433 -5.674 -10.91 12.851
Non-Cash Items 5.858 14.155 449.903 168.439
Cash Taxes Paid 11.7 19.4 29.228 18.105
Cash Interest Paid 18.658 48.443 24.517 20.198
Changes in Working Capital -11.771 -4.816 -32.459 -11.796
Cash From Investing Activities -3.458 -37.055 -91.617 -178.733
Capital Expenditures -3.458 -5.749 -35.824 -34.457
Other Investing Cash Flow Items, Total 0 -31.306 -55.793 -144.276
Cash From Financing Activities -24.734 -54.781 905.817 -30.528
Financing Cash Flow Items -1371.97 -2.214 15.043 -58.52
Issuance (Retirement) of Stock, Net 740.358 4.665 897.803 35.021
Issuance (Retirement) of Debt, Net 606.876 -57.232 -7.029 -7.029
Net Change in Cash 17.061 -8.55 945.541 -30.482
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line 1.668 32.729 14.66 -25.254 12.293
Cash From Operating Activities 45.485 80.411 128.969 178.779 30.12
Cash From Operating Activities 5.361 13.73 23.891 34.539 11.373
Deferred Taxes -0.227 -0.364 -33.217 12.851 -0.394
Non-Cash Items 48.261 91.5 133.649 168.439 31.732
Changes in Working Capital -9.578 -57.184 -10.014 -11.796 -24.884
Cash From Investing Activities -9.695 -142.416 -169.474 -178.733 -34.401
Capital Expenditures -9.695 -16.688 -25.198 -34.457 -12.418
Cash From Financing Activities -14.018 -14.883 -19.063 -30.528 -91.401
Financing Cash Flow Items -14.633 -26.849 -43.506 -58.52 -9.561
Issuance (Retirement) of Stock, Net 2.372 15.481 29.715 35.021 -80.082
Issuance (Retirement) of Debt, Net -1.757 -3.515 -5.272 -7.029 -1.758
Net Change in Cash 21.772 -76.888 -59.568 -30.482 -95.682
Other Investing Cash Flow Items, Total -125.728 -144.276 -144.276 -21.983
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 9.4792 7816360 739017 2022-09-30 LOW
Millennium Management LLC Hedge Fund 5.3318 4396531 2279989 2022-12-13 HIGH
Light Street Capital Management, LLC Investment Advisor/Hedge Fund 5.0836 4191872 -437404 2022-09-30 HIGH
Marshall Wace LLP Investment Advisor/Hedge Fund 4.3934 3622709 55218 2022-09-30 HIGH
Silver Lake Partners Private Equity 4.2837 3532276 0 2022-09-30 LOW
Slutsky (Andrew) Individual Investor 3.887 3205126 31512 2022-04-19 LOW
Two Sigma Investments, LP Hedge Fund 3.6134 2979556 -63560 2022-09-30 HIGH
Renaissance Technologies LLC Hedge Fund 2.6942 2221622 -1024000 2022-09-30 HIGH
Perot Investments Investment Advisor/Hedge Fund 2.6238 2163566 359632 2022-09-30 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 2.0657 1703329 234672 2022-09-30 LOW
Technology Crossover Ventures Venture Capital 2.0053 1653566 0 2022-09-30 LOW
Jacobs Levy Equity Management, Inc. Investment Advisor/Hedge Fund 1.8559 1530333 1530333 2022-09-30 MED
Voloridge Investment Management, LLC Investment Advisor/Hedge Fund 1.4858 1225186 806904 2022-09-30 HIGH
Norwood Investment Partners, LP Investment Advisor 1.4808 1221000 1194742 2022-09-30 HIGH
Morgan Stanley & Co. LLC Research Firm 1.385 1142009 594803 2022-09-30 MED
D. E. Shaw & Co., L.P. Hedge Fund 1.1537 951343 -137008 2022-09-30 MED
Schroder Investment Management Ltd. (SIM) Investment Advisor/Hedge Fund 0.9515 784568 260599 2022-09-30 LOW
Manulife Investment Management (North America) Limited Investment Advisor 0.8914 735028 352110 2022-09-30 LOW
Goldman Sachs & Company, Inc. Research Firm 0.8566 706359 254727 2022-09-30 MED
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 0.8553 705300 705300 2021-12-31 LOW

Why choose Capital.com? Our numbers speak for themselves.

Capital.com Group
+485000+

Traders

65000+

Active clients monthly

$48000000+

Monthly investing volume

$28000000+

Withdrawn each month

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

GoodRx Holdings, Inc. Company profile

GoodRx is a startup company that operates a telemedicine platform and a free-to-use website and mobile app that track prescription drug prices in the United States and provide free drug coupons for discounts on medications. GoodRx checks more than 75,000 pharmacies in the United States. The website gets about fourteen million visitors a month. As of February 25, 2020, "millions of people" had downloaded the GoodRx app.
Industry: Online Services (NEC)

2701 Olympic Boulevard
Suite 990
SANTA MONICA
CALIFORNIA 90404
US

Income Statement

  • Annual
  • Quarterly

People also watch

US100

12,164.80 Price
+1.340% 1D Chg, %
Long position overnight fee -0.0179%
Short position overnight fee 0.0070%
Overnight fee time 22:00 (UTC)
Spread 3.0

ETH/USD

1,602.11 Price
-0.080% 1D Chg, %
Long position overnight fee -0.0500%
Short position overnight fee 0.0140%
Overnight fee time 22:00 (UTC)
Spread 5.50

XRP/USD

0.41 Price
-0.300% 1D Chg, %
Long position overnight fee -0.0500%
Short position overnight fee 0.0140%
Overnight fee time 22:00 (UTC)
Spread 0.00299

BTC/USD

23,272.70 Price
+0.610% 1D Chg, %
Long position overnight fee -0.0500%
Short position overnight fee 0.0140%
Overnight fee time 22:00 (UTC)
Spread 66.00

Still looking for a broker you can trust?

Join the 480.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading